Journals A-Z
All Subjects
Free Journals
sciepub.com
American Journal of Food and Nutrition
ISSN (Print): 2374-1155 ISSN (Online): 2374-1163 Website: https://www.sciepub.com/journal/ajfn Editor-in-chief: Mihalis Panagiotidis
Open Access
Journal Browser
Go
Issue 4, Volume 14
Article Metrics
  • 23
    Views
  • 58
    Saves
  • 0
    Citations
  • 0
    Likes
Export Article
American Journal of Food and Nutrition. 2026, 14(4), 165-185
DOI: 10.12691/ajfn-14-4-4
Open AccessArticle

Preventive and Protective Effects of Gum Arabic against Cisplatin-Induced Acute Kidney Injury in Rats: An Integrated Biochemical and Histological Study

Yousif A. Elhassaneen1, , Asmaa Bioumy2 and Esraa Z. Badawy1

1Department of Nutrition and Food Science, Faculty of Home Economics, Menoufia University, Shebin El-Kom, Egypt

2Department of Zoology, , Faculty of Science, Menoufia University, Shebin El-Kom, Egypt

Pub. Date: October 25, 2026
View Full Text Full Text PDF (1497 KB) Full Text ePUB(1962 KB)

Cite this paper:
Yousif A. Elhassaneen, Asmaa Bioumy and Esraa Z. Badawy. Preventive and Protective Effects of Gum Arabic against Cisplatin-Induced Acute Kidney Injury in Rats: An Integrated Biochemical and Histological Study. American Journal of Food and Nutrition. 2026; 14(4):165-185. doi: 10.12691/ajfn-14-4-4

Abstract

This study investigated the preventive and protective effects of Gum Arabic (GA) against cisplatin-induced acute kidney injury in 48 rats through biochemical and histopathological assessments. Rats were assigned to a normal control, cisplatin model, preventive GA groups receiving 2%, 3%, or 4%, and therapeutic groups for 28 days. Cisplatin reduced body weight gain and feed efficiency, increased kidney weight by 39.42%, increased serum AST, ALT, and ALP by 138.18%, 133.88%, and 106.49%, respectively, and decreased albumin by 46.46%. Renal dysfunction was pronounced, with urea, creatinine, and uric acid increasing by 406.24%, 380.77%, and 114.85%, respectively. Cisplatin suppressed renal GPx, SOD, and CAT activities by 65.28%, 42.99%, and 46.98%, while MDA and protein carbonyl increased by 98.05% and 200%. GA improved the parameters, with responses observed in preventive groups and at 4% concentration. Preventive 4% GA reduced urea, creatinine, and uric acid by 54.70%, 52.00%, and 42.88%, respectively, and increased GPx, SOD, and CAT activities by 68.12%, 59.17%, and 69.55%. It reduced MDA by 32.18% and protein carbonyl by 52.71%. Hematological abnormalities were attenuated, including improvements in RBCs, hemoglobin, hematocrit, and platelets, while leukocyte recovery was limited. Correlations showed associations between oxidative stress and renal dysfunction, including MDA with urea (r=+0.8150) and creatinine (r=+0.7737), and inverse relationships between MDA and GPx (r=-0.8623), SOD (r=-0.8217), and CAT (r=-0.7946). Histopathology confirmed tubular necrosis, inflammation, congestion, and vacuolar degeneration in cisplatin-treated rats, whereas GA reduced lesions and promoted tubular preservation and repair. Overall, GA, particularly 4% GA, demonstrated renoprotective effects against cisplatin-induced kidney injury.

Keywords:
Dietary intervention lipid peroxidation protein oxidation hepatic biomarkers antioxidant defense renal oxidative stress renal histology

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Hall, J. E. (2021). Guyton and Hall textbook of medical physiology (14th ed.). Elsevier.
 
[2]  KDIGO CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117–S314.
 
[3]  Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O'Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. (2016). Global prevalence of chronic kidney disease: A systematic review and meta-analysis. PLOS ONE, 11(7), e0158765.
 
[4]  Abd ElHafeez, S., Bolignano, D., D'Arrigo, G., Dounousi, E., Tripepi, G., & Zoccali, C. (2018). Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: A systematic review. BMJ Open, 8(1), e015069.
 
[5]  Gamal, S., Elseasi, A. M. A., Sabry, N. A., & Farid, S. F. (2025). Impact of pharmacist-led mobile application on medication adherence and efficacy in chronic kidney disease. npj Digital Medicine, 8, 325.
 
[6]  Ghonemy, T. A., Farag, S. E., Soliman, S. A., El-Okely, A., & El-Hendy, Y. (2016). Epidemiology and risk factors of chronic kidney disease in the El-Sharkia Governorate, Egypt. Saudi Journal of Kidney Diseases and Transplantation, 27(1), 111–117.
 
[7]  Nishiyama, H., Inoue, T., Koizumi, Y., Kobayashi, Y., Kitamura, H., Yamamoto, K., Takeda, T., Yamamoto, T., Yamamoto, R., Matsubara, T., Hoshino, J., & Yanagita, M. (2023). Chapter 2: Indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022. International Journal of Clinical Oncology, 28(10), 1298–1314.
 
[8]  Renaghan, A. D., Ostermann, M., Ronco, C., Ballen, K., Cosmai, L., Fenoglio, R., Floris, M., Forni, L. G., Gladstone, D. E., Glezerman, I. G., Goldstein, S. L., Gupta, S., Herrmann, S. M., Jaimes, E. A., Jhaveri, K. D., Karam, S., Kitchlu, A., Landau, H. J., Latcha, S., Leaf, D. E., Lentini, P., Małyszko, J., Markowitz, G., Murakami, N., Pani, A., Perazella, M. A., Rashidi, A., Roccatello, D., Sharon, E., Sprangers, B., Tesař, V., Torres, V., Wanchoo, R., Whitman, A., Workeneh, B. T., Zepeda-Orozco, D., & Rosner, M. H. (2026). The nephrotoxic effects of anti-cancer therapies: Consensus report of the 34th Acute Disease Quality Initiative workgroup. Nature Reviews Nephrology, 22(4), 283–300.
 
[9]  Tang, C., Livingston, M. J., Safirstein, R., & Dong, Z. (2023). Cisplatin nephrotoxicity: New insights and therapeutic implications. Nature Reviews Nephrology, 19(1), 53–72.
 
[10]  Hamroun, A., Lenain, R., Bigna, J. J., Speyer, E., Bui, L., Chamley, P., Pottier, N., Cauffiez, C., Dewaeles, E., Dhalluin, X., Scherpereel, A., Hazzan, M., Maanaoui, M., & Glowacki, F. (2019). Prevention of cisplatin-induced acute kidney injury: A systematic review and meta-analysis. Drugs, 79(14), 1567–1582.
 
[11]  Al-Ghamdi, S., Abu-Alfa, A., Alotaibi, T., AlSaaidi, A., AlSuwaida, A., Arici, M., Ecder, T., El Koraie, A. F., Ghnaimat, M., Hafez, M. H., Hassan, M., & Sqalli, T. (2023). Chronic kidney disease management in the Middle East and Africa: Concerns, challenges, and novel approaches. International Journal of Nephrology and Renovascular Disease, 16, 103–112.
 
[12]  Nkunu, V., Tungsanga, S., Diongole, H. M., Sarki, A., Arruebo, S., Caskey, F. J., Damster, S., Donner, J. A., Jha, V., Levin, A., Nangaku, M., Saad, S., Ye, F., Okpechi, I. G., Bello, A. K., Johnson, D. W., & Tonelli, M. (2024). Landscape of kidney replacement therapy provision in low- and lower-middle income countries: A multinational study from the ISN-GKHA. PLOS Global Public Health, 4(12), e0003979.
 
[13]  Carrero, J. J., González-Ortiz, A., Avesani, C. M., Bakker, S. J. L., Bellizzi, V., Chauveau, P., Clase, C. M., Cupisti, A., Espinosa-Cuevas, A., Molina, P., Moreau, K., Piccoli, G. B., Post, A., Sezer, S., & Fouque, D. (2020). Plant-based diets to manage the risks and complications of chronic kidney disease. Nature Reviews Nephrology, 16(9), 525–542.
 
[14]  Anderson, D. M., Douglas, D. M., Morrison, N. A., & Wang, W. P. (1990). Specifications for gum arabic (Acacia senegal): Analytical data for samples collected between 1904 and 1989. Food Additives and Contaminants, 7(3), 303–321.
 
[15]  Elhassaneen, Y. A., El-Sayed, M. M., & Hassan, H. H. (2014). The effect of some food products mixed with plant parts on blood sugar levels of rats. In Proceedings of the 3rd International–17th Arab Conference of Home Economics (pp. 85–109). Faculty of Home Economics, Minoufiya University, Egypt
 
[16]  El-Agooze, S. A. M. (2016). Evaluation and modification of courses of food for kidney patients [Master’s thesis, Faculty of Agriculture, Mansoura University, Egypt].
 
[17]  Radwan, H., Abd El-Khalik, D., & Elhassaneen, Y. (2018). Studies on the antioxidant and antibacterial properties of phyto-by-products and gum Arabic extracts in cooked beef meatballs. In Proceedings of the 5th Scientific (3rd International) Conference of the Faculty of Specific Education, Ain Shams University: The Modern Global Orientations and the Development of the Specific Education (February 20–22, 2018). Ain El-Sokhna, Egypt.
 
[18]  Elhassaneen, Y. A., Abd Elmanam, R. S., Negm, S. H., & Mahmoud, S. A. (2023). Phyto-extracts of some by-products/wastes of food factories attenuate alloxan-induced diabetes mellitus and its complications in rats. Port Said Specific Research Journal, 22, 493–515.
 
[19]  Prasad, N., Thombare, N., Sharma, S. C., & Kumar, S. (2022). Gum arabic—A versatile natural gum: A review on production, processing, properties and applications. Industrial Crops and Products, 187, 115304.
 
[20]  Randall, R. C., Phillips, G. O., & Williams, P. A. (1988). The role of the proteinaceous component in the emulsifying properties of gum arabic. Food Hydrocolloids, 2(2), 131–140.
 
[21]  Goodrum, L. J., Patel, A., Leykam, J. F., & Kieliszewski, M. J. (2000). Gum arabic glycoprotein contains glycomodules of both extensin and arabinogalactan-glycoproteins. Phytochemistry, 54(1), 99–106.
 
[22]  Domma, M. B., Elhassaneen, Y., Ibrahim, F. Y., & El-Agooze, S. A. (2016). Biological effects of gum Arabic on chronic kidney disease in rats. Journal of Biological Chemistry and Environmental Sciences, 11(3), 163–184.
 
[23]  Abd El-Khader, Y. I. (2018-a). Production of some functional foods using gum Arabic to ameliorate the complications arising from kidney disease in rats [Master’s thesis, Faculty of Home Economics, Minoufiya University, Egypt].
 
[24]  Al-Jubori, Y., Ahmed, N. T. B., Albusaidi, R., Madden, J., Das, S., & Sirasanagandla, S. R. (2023). The efficacy of gum arabic in managing diseases: A systematic review of evidence-based clinical trials. Biomolecules, 13(1), 138.
 
[25]  Bliss, D. Z., Stein, T. P., Schleifer, C. R., & Settle, R. G. (1996). Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet. The American Journal of Clinical Nutrition, 63(3), 392–398
 
[26]  Ali, B. H., Ziada, A., & Blunden, G. (2009). Biological effects of gum arabic: A review of some recent research. Food Chem Toxicol. 47(1):1-8.
 
[27]  Elhassaneen, Y. A., Ragab, S., Nasef, A., & Abd El-Khader, Y. (2018). Production of functional foods using gum Arabic to ameliorate kidney disease complications in rats. In Proceedings of the Annual Conference (13th Arab; 10th International), Faculty of Specific Education, Mansoura University, Egypt.
 
[28]  Elhassaneen, Y. A., Abdel Rhman, A. N., & Hussin, N. A. (2021). The potential effects of psyllium seeds and its husks (Plantago ovata) on diabetic rats. Journal of Home Economics, 31(2), 36–48.
 
[29]  Elhassaneen, Y. A., Emam, O. A., ElBassouny, G. M., & Ahmed, A. T. (2022-a). Chemical composition, physical properties, nutritional value, bioactive compounds content and biological activities of gum Arabic (Acacia seyal). Journal of the College of Specific Education for Educational and Specific Studies, 7(22), 497–527.
 
[30]  Elhassaneen, Y. A., ElKhamisy, A., Sayed-Ahmed, R., & El-Sakoty, S. (2022-b). Potential biological effects of gum Arabic on kidney disorders induced by arginine in rats. Port Said Specific Research Journal, 15(1), 1015–1035.
 
[31]  Elhassaneen, Y. A., Refat, W. A., & Ragab, H. E. (2026). Ameliorative effects of gum Arabic on arginine-induced renal injury in rats: Influence on oxidative stress, organ functions, inflammation, and lipid profile. American Journal of Food and Nutrition, 14(3), 98–113.
 
[32]  Elamin, S., Alkhawaja, M. J., Bukhamsin, A. Y., Idris, M. A. S., Abdelrahman, M. M., Abutaleb, N. K., & Housawi, A. A. (2017). Gum Arabic reduces C-reactive protein in chronic kidney disease patients without affecting urea or indoxyl sulfate levels. International Journal of Nephrology, 2017, 9501470.
 
[33]  Ali, N. E., Kaddam, L. A., Alkarib, S. Y., Kaballo, B. G., Khalid, S. A., Higawee, A., AbdElhabib, A., AlaaAldeen, A., Phillips, A. O., & Saeed, A. M. (2020). Gum Arabic (Acacia senegal) augmented total antioxidant capacity and reduced C-reactive protein among haemodialysis patients in phase II trial. International Journal of Nephrology, 2020, 7214673.
 
[34]  Reeves, P.; Nielsen, F. and Fahey, G.(1993): "AIN-93 Purified Diets for Laboratory Rodents: Final Report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet". Journal of Nutrition, 123(11): 1939-1951.
 
[35]  Mohammed, N. H. (2014). Chemical and technological studies on some food products supplemented with gum Arabic [Master’s thesis, Faculty of Home Economics, Menoufia University, Egypt].
 
[36]  Hegazy, W. H. I. (2014). New trends for using gum Arabic in food processing applications [Doctoral dissertation, Faculty of Home Economics, Menoufia University, Egypt].
 
[37]  Chapman, D.G., Castilla, R., Champbell, J.A. (1959). "Evaluation of protein in food". I.A. Method for the determination of protein efficiency ratio". Can. J. Biochemistry Physiology, vol. 37, pp679-686.Chem., (23): 282.
 
[38]  Schermer, S. (1967). The blood morphology of laboratory animals (3rd ed.). Davis.
 
[39]  Wang, T., Shen, W., Li, L., Wang, H., & Zhang, M. (2024). Comparison of preparation methods of rat kidney single-cell suspensions. Scientific Reports, 14, 2785.
 
[40]  Tietz, N. W. (1976). Fundamentals of clinical chemistry (p. 243). W. B. Saunders.
 
[41]  Vassault, A.; Grafmeyer, D.; Graeve, J.; Cohen, R.; Beaudonnet, A.; and Bienvenu, J. (1999): Quality specifications and allowable standards for validation of methods used in clinical biochemistry.Ann Biol Clin (Paris)., 57(6): 685-95
 
[42]  Doumas, B. T., Watson, W. A., & Biggs, H. G. (1971). Albumin standards and the measurement of serum albumin with bromcresol green. Clinica Chimica Acta, 31(1), 87–96.
 
[43]  Gornall, A. G., Bardawill, C. J., & David, M. M. (1949). Determination of serum proteins by means of the biuret reaction. Journal of Biological Chemistry, 177(2), 751–766.
 
[44]  Faweett, J. K., & Scott, J. E. (1960). Determination of urea. Journal of Clinical Pathology, 13, 156–159.
 
[45]  Bartels, J., Bohmer, M., & Heirli, C. (1972). Determination of creatinine. Clinica Chimica Acta, 37, 193.
 
[46]  Barham, D., & Trinder, P. (1972). Determination of uric acid. The Analyst, 97, 142.
 
[47]  Splittgerber, A. G., & Tappel, A. L. (1979). Inhibition of glutathione peroxidase by metals. Archives of Biochemistry and Biophysics, 197, 534–542.
 
[48]  Engelbrecht, I., Horn, S., Giesy, J.P., Pieters, R. (2023). Determining superoxide dismutase content and catalase activity in mammalian cell lines. MethodsX. 11:102395.
 
[49]  Buege, J. A., & Aust, S. D. (1978). Microsomal lipid peroxidation. In L. Packer (Ed.), Methods in enzymology (Vol. 52, pp. 302–310). Academic Press.
 
[50]  Carleton, H. M. (1980). Carleton’s histological technique (5th ed.). Oxford University Press. [54] Manohar, S., & Leung, N. (2018). Cisplatin nephrotoxicity: A review of the literature. Journal of Nephrology, 31(1), 15–25.
 
[51]  Steel, R. G. D., & Torrie, J. H. (1980). Principles and procedures of statistics. McGraw-Hill.
 
[52]  Ozkok, A., & Edelstein, C. L. (2014). Pathophysiology of cisplatin-induced acute kidney injury. BioMed Research International, 2014, 967826.
 
[53]  Dasari, S., & Tchounwou, P. B. (2014). Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology, 740, 364–378..
 
[54]  Manohar, S., & Leung, N. (2018). Cisplatin nephrotoxicity: A review of the literature. Journal of Nephrology, 31(1), 15–25.
 
[55]  Ali, B. H., Al-Husseni, I., Beegam, S., Al-Shukaili, A., Nemmar, A., Schierling, S., Queisser, N., & Schupp, N. (2013). Effect of gum Arabic on oxidative stress and inflammation in adenine-induced chronic renal failure in rats. PLoS ONE, 8(2), e55242.
 
[56]  Ali, B. H. (2004). Does gum arabic have an antioxidant action in rat kidney? Renal Failure, 26(1), 1–3.
 
[57]  Al-Majed, A. A., Abd-Allah, A. R., Al-Rikabi, A. C., Al-Shabanah, O. A., & Mostafa, A. M. (2003). Effect of oral administration of Arabic gum on cisplatin-induced nephrotoxicity in rats. Journal of Biochemical and Molecular Toxicology, 17(3), 146–153.
 
[58]  Nematbakhsh, M., Ashrafi, F., Nasri, H., Talebi, A., Pezeshki, Z., Eshraghi, F., & Haghighi, M. (2013). A model for prediction of cisplatin-induced nephrotoxicity by kidney weight in experimental rats. Journal of Research in Medical Sciences, 18(5), 370–373.
 
[59]  Martins, N. M., Santos, N. A., Curti, C., Bianchi, M. L., & Santos, A. C. (2008). Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. Journal of Applied Toxicology, 28(3), 337–344.
 
[60]  Palipoch, S., & Punsawad, C. (2013). Biochemical and histological study of rat liver and kidney injury induced by cisplatin. Journal of Toxicologic Pathology, 26(3), 293–299.
 
[61]  Paranavitane, V., Tungsanga, S., Diongole, H. M., Sarki, A., Arruebo, S., Caskey, F. J., Damster, S., Donner, J. A., Jha, V., Levin, A., Nangaku, M., Saad, S., Ye, F., Okpechi, I. G., Bello, A. K., Johnson, D. W., & Tonelli, M. (2007). Landscape of kidney replacement therapy provision in low- and lower-middle income countries: A multinational study from the ISN-GKHA. PLOS Global Public Health, 4(12), e0003979.
 
[62]  Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010). Mechanisms of cisplatin nephrotoxicity. Toxins, 2(11), 2490–2518.
 
[63]  Li, S., Livingston, M. J., Ma, Z., Hu, X., Wen, L., Ding, H. F., Zhou, D., & Dong, Z. (2023). Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight, 8(8), e166643.
 
[64]  Peres, L. A., & da Cunha, A. D., Jr. (2013). Acute nephrotoxicity of cisplatin: Molecular mechanisms. Jornal Brasileiro de Nefrologia, 35(4), 332–340.
 
[65]  Sugiyama, S., Hayakawa, M., Kato, T., Hanaki, Y., Shimizu, K., & Ozawa, T. (1989). Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activity. Biochemical and Biophysical Research Communications, 159(3), 1121–1127.
 
[66]  Badary, O. A., Abdel-Maksoud, S., Ahmed, W. A., & Owieda, G. H. (2005). Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sciences, 76(18), 2125–2135.
 
[67]  Almaghrabi, O. A. (2015). Molecular and biochemical investigations on the effect of quercetin on oxidative stress induced by cisplatin in rat kidney. Saudi Journal of Biological Sciences, 22(2), 227–231.
 
[68]  Atessahin, A., Yilmaz, S., Karahan, I., Ceribasi, A. O., & Karaoglu, A. (2005). Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology, 212(2–3), 116–123.
 
[69]  Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007). Cisplatin nephrotoxicity: A review. The American Journal of the Medical Sciences, 334(2), 115–124.
 
[70]  Volarevic, V., Djokovic, B., Jankovic, M. G., Harrell, C. R., Fellabaum, C., Djonov, V., & Arsenijevic, N. (2019). Molecular mechanisms of cisplatin-induced nephrotoxicity: A balance on the knife edge between renoprotection and tumor toxicity. Journal of Biomedical Science, 26(1), 25.
 
[71]  Kruidering, M., Van de Water, B., de Heer, E., Mulder, G. J., & Nagelkerke, J. F. (1997). Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: Mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. Journal of Pharmacology and Experimental Therapeutics, 280(2), 638–649.
 
[72]  Kang, T., Suzuki, H., Makita, Y., Nihei, Y., Fukao, Y., Nakayama, M., Lee, M., Kato, R., Aoki, R., Yamada, K., Muto, M., & Suzuki, Y. (2018). Mucosal immune system dysregulation in the pathogenesis of IgA nephropathy. Biomedicines, 10(12), 3027.
 
[73]  Rjiba-Touati, K., Boussema, I. A., Belarbia, A., Achour, A., & Bacha, H. (2011). Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney. International Journal of Toxicology, 30(5), 510–517.
 
[74]  Elnour, A. A. M., Abdurahman, N. H., Musa, K. H., & Rasheed, Z. (2023). Prebiotic potential of gum Arabic for gut health. International Journal of Health Sciences, 17(6), 4–5.
 
[75]  Işeri, S., Ercan, F., Gedik, N., Yüksel, M., & Alican, I. (2007). Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology, 230(2–3), 256–264.
 
[76]  Santos, N. A., Catão, C. S., Martins, N. M., Curti, C., Bianchi, M. L., & Santos, A. C. (2007). Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Archives of Toxicology, 81(7), 495–504.
 
[77]  Abdel-Daim, M. M., Abdel-Rahman, H. G., Dessouki, A. A., El-Far, A. H., Khodeer, D. M., Bin-Jumah, M., Alhader, M. S., Alkahtani, S., & Aleya, L. (2020). Impact of garlic (Allium sativum) oil on cisplatin-induced hepatorenal biochemical and histopathological alterations in rats. Science of the Total Environment, 710, 136338.
 
[78]  Lee, H. S., Kim, B. K., Nam, Y., Sohn, U. D., Park, E. S., Hong, S. A., Lee, J. H., Chung, Y. H., & Jeong, J. H. (2013). Protective role of phosphatidylcholine against cisplatin-induced renal toxicity and oxidative stress in rats. Food and Chemical Toxicology, 58, 388–393.
 
[79]  Ali, B. H., Al Za’abi, M., Shalaby, A., Manoj, P., Waly, M. I., Yasin, J., Fahim, M., & Nemmar, A. (2022). The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles. Experimental Biology and Medicine, 240, 1698–1707.
 
[80]  Nofal, A. E., Okdah, Y. A., Rady, M. I., & Hassaan, H. Z. (2023). Gum acacia attenuates cisplatin toxic effect spermatogenesis dysfunction and infertility in rats. International Journal of Biological Macromolecules, 240, 124292.
 
[81]  McSweeney, K. R., Gadanec, L. K., Qaradakhi, T., Ali, B. A., Zulli, A., & Apostolopoulos, V. (2021). Mechanisms of cisplatin-induced acute kidney injury: Pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers, 13(7), 1572.
 
[82]  Nasir, O. (2013). Renal and extrarenal effects of gum Arabic (Acacia senegal)—What can be learned from animal experiments? Kidney and Blood Pressure Research, 37(4–5), 269–279.
 
[83]  Al-Majed, A. A., Mostafa, A. M., Al-Rikabi, A. C., & Al-Shabanah, O. A. (2002). Protective effects of oral Arabic gum administration on gentamicin-induced nephrotoxicity in rats. Pharmacological Research, 46(5), 445–451.
 
[84]  Habashy, N. H., & Abu-Serie, M. M. (2024). Attenuation of carbon tetrachloride-induced nephrotoxicity by gum Arabic extract via modulating cellular redox state, NF-κB pathway, and KIM-1. Biomedicine & Pharmacotherapy, 173, 116340.
 
Manuscript template